De Santo NG - Search Results

1

Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia.

Perna AF, Ingrosso D, De Santo NG, Galletti P, Brunone M, Zappia V. Perna AF, et al. Among authors: de santo ng. J Am Soc Nephrol. 1997 Dec;8(12):1899-905. doi: 10.1681/ASN.V8121899. J Am Soc Nephrol. 1997. PMID: 9402092 Clinical Trial.

2

Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: cardiovascular and metabolic consequences.

Perna AF, Capasso R, Acanfora F, Satta E, Lombardi C, Ingrosso D, Violetti E, Romano MM, De Santo NG. Perna AF, et al. Among authors: de santo ng. Semin Nephrol. 2006 Jan;26(1):20-3. doi: 10.1016/j.semnephrol.2005.06.005. Semin Nephrol. 2006. PMID: 16412820 Review.

3

L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis.

Perna AF, Acanfora F, Satta E, Lombardi C, Capasso R, Ingrosso D, De Santo NG. Perna AF, et al. Among authors: de santo ng. J Nephrol. 2007 Jan-Feb;20(1):63-5. J Nephrol. 2007. PMID: 17347975 Clinical Trial.

4

Homocysteine in uremia.

Perna AF, Ingrosso D, Lombardi C, Cesare CM, Acantora F, Satta E, De Santo NG. Perna AF, et al. Among authors: de santo ng. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S123-6. doi: 10.1053/ajkd.2003.50100. Am J Kidney Dis. 2003. PMID: 12612968 Review.

5

Plasma protein aspartyl damage is increased in hemodialysis patients: studies on causes and consequences.

Perna AF, Ingrosso D, Satta E, Lombardi C, Galletti P, D'Aniello A, De Santo NG. Perna AF, et al. Among authors: de santo ng. J Am Soc Nephrol. 2004 Oct;15(10):2747-54. doi: 10.1097/01.ASN.0000141041.71717.11. J Am Soc Nephrol. 2004. PMID: 15466280

6

Hyperhomocysteinemia and cardiovascular disease in uremia: the newest evidence in epidemiology and mechanisms of action.

Perna AF, Acanfora F, Satta E, Lombardi C, Ingrosso D, De Santo NG. Perna AF, et al. Among authors: de santo ng. Semin Nephrol. 2004 Sep;24(5):426-30. doi: 10.1016/j.semnephrol.2004.06.019. Semin Nephrol. 2004. PMID: 15490404 Review.

7

Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine.

Perna AF, Ingrosso D, Zappia V, Galletti P, Capasso G, De Santo NG. Perna AF, et al. Among authors: de santo ng. J Clin Invest. 1993 Jun;91(6):2497-503. doi: 10.1172/JCI116485. J Clin Invest. 1993. PMID: 8514862 Free PMC article.

8

Adverse effects of hyperhomocysteinemia and their management by folic acid.

Perna AF, De Santo NG, Ingrosso D. Perna AF, et al. Among authors: de santo ng. Miner Electrolyte Metab. 1997;23(3-6):174-8. Miner Electrolyte Metab. 1997. PMID: 9387111 Review.

9

Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications.

Perna AF, Ingrosso D, Castaldo P, De Santo NG, Galletti P, Zappia V. Perna AF, et al. Among authors: de santo ng. Miner Electrolyte Metab. 1999 Jan-Apr;25(1-2):95-9. doi: 10.1159/000057428. Miner Electrolyte Metab. 1999. PMID: 10207268 Review.

10

Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin.

Perna AF, Castaldo P, Ingrosso D, De Santo NG. Perna AF, et al. Among authors: de santo ng. J Nephrol. 1999 Jul-Aug;12(4):230-40. J Nephrol. 1999. PMID: 10493566 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters